Shariat SF - Search Results

1

Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.

Yanagisawa T, Rajwa P, Thibault C, Gandaglia G, Mori K, Kawada T, Fukuokaya W, Shim SR, Mostafaei H, Motlagh RS, Quhal F, Laukhtina E, Pallauf M, Pradere B, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Among authors: shariat sf. Eur Urol. 2022 Dec;82(6):584-598. doi: 10.1016/j.eururo.2022.08.002. Epub 2022 Aug 19. Eur Urol. 2022. PMID: 35995644 Free article. Review.

2

Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.

Shariat SF, Abdel-Aziz KF, Roehrborn CG, Lotan Y. Shariat SF, et al. Eur Urol. 2006 Feb;49(2):293-302. doi: 10.1016/j.eururo.2005.10.027. Epub 2005 Dec 20. Eur Urol. 2006. PMID: 16387412

3

Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy.

Shariat SF, Palapattu GS, Amiel GE, Karakiewicz PI, Rogers CG, Vazina A, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y. Shariat SF, et al. Urology. 2006 Sep;68(3):538-42. doi: 10.1016/j.urology.2006.03.033. Epub 2006 Sep 18. Urology. 2006. PMID: 16979748

4

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF. Karam JA, et al. Among authors: shariat sf. Urology. 2007 Sep;70(3):482-6. doi: 10.1016/j.urology.2007.05.009. Urology. 2007. PMID: 17905101

5

Challenges of cancer biomarker profiling.

Bensalah K, Montorsi F, Shariat SF. Bensalah K, et al. Among authors: shariat sf. Eur Urol. 2007 Dec;52(6):1601-9. doi: 10.1016/j.eururo.2007.09.036. Epub 2007 Oct 1. Eur Urol. 2007. PMID: 17919807 Review.

6

Nomograms for bladder cancer.

Shariat SF, Margulis V, Lotan Y, Montorsi F, Karakiewicz PI. Shariat SF, et al. Eur Urol. 2008 Jul;54(1):41-53. doi: 10.1016/j.eururo.2008.01.004. Epub 2008 Jan 15. Eur Urol. 2008. PMID: 18207314 Review.

7

Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.

Shariat SF, Walz J, Roehrborn CG, Montorsi F, Jeldres C, Saad F, Karakiewicz PI. Shariat SF, et al. J Urol. 2008 Apr;179(4):1593-7. doi: 10.1016/j.juro.2007.11.044. Epub 2008 Mar 4. J Urol. 2008. PMID: 18295256

8

Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.

Gupta A, Lotan Y, Bastian PJ, Palapattu GS, Karakiewicz PI, Raj GV, Schoenberg MP, Lerner SP, Sagalowsky AI, Shariat SF; Bladder Cancer Research Consortium. Gupta A, et al. Among authors: shariat sf. Urology. 2008 Feb;71(2):302-7. doi: 10.1016/j.urology.2007.10.041. Urology. 2008. PMID: 18308108

9

Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.

Gupta A, Lotan Y, Ashfaq R, Roehrborn CG, Raj GV, Aragaki CC, Montorsi F, Shariat SF. Gupta A, et al. Among authors: shariat sf. Eur Urol. 2009 May;55(5):1124-33. doi: 10.1016/j.eururo.2008.06.054. Epub 2008 Jun 23. Eur Urol. 2009. PMID: 18585843

10

Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.

Yee DS, Shariat SF, Lowrance WT, Sterbis JR, Vora KC, Bochner BH, Donat SM, Herr HW, Dalbagni G, Sandhu JS. Yee DS, et al. Among authors: shariat sf. J Urol. 2010 May;183(5):1751-6. doi: 10.1016/j.juro.2010.01.014. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299035 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,823 results

Search Page